Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 271-278

  Lichy, Jack H ^a   Zavar, Maryam ^a   Tsai, Mark M ^a   O'Leary, Timothy J ^a   Taubenberger, Jeffery K ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CHROMOSOME 11P; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL;

EID: 0031820625     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65568-X     Document Type: Article

References (42)

1. Ali IU, Lidereau R, Theillet C, Callahan R: Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science 1987, 238:185-188
2. Gudmundsson J, Barkardottir RB, Eiriksdottir G, Baldursson T, Arason A, Egilsson V, Ingvarsson S: Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 1995, 72:696-701
3. Mackay J, Elder PA, Porteous DJ, Steel CM, Hawkins RA, Going JJ: Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br J Cancer 1988, 58:710-714
4. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, Croce CM: Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 1995, 55:3003-3007
5. Takita K, Sato T, Miyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R, Nakamura Y: Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 1992, 52:3914-3917
6. Winqvist R, Hampton GM, Nannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I, Cavenee WK: Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 1995, 55:2660-2664
7. Winqvist R, Mannermaa A, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee W: Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res 1993, 53:4486-4488
8. Bepler G, Garcia-Blanco MA: Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA 1994, 91:5513-5517
9. Fong KM, Zimmerman PV, Smith PJ: Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer. Genes Chromosomes & Cancer 1994, 10:183-189
10. Ludwig CU, Raefle G, Dalquen P, Stulz P, Stahel R, Obrecht JP: Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer. Int J Cancer 1991, 49:661-665
11. Tran YK, Newsham IF: High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res 1996, 56:2916-2921
12. Weston A, Willey JC, Modali R, Sugimura H, McDowell EM, Resau J, Light B, Haugen A, Mann DL, Trump BF, Harris CC: Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 1989, 86:5099-5103
13. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelein D, Coll J, Riou G: High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas: uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 1996, 12:423-430
14. Smith RC, Rukstalis DB: Frequent loss of heterozygosity at 11p loci in testicular cancer. J Urol 1995, 153:1684-1687
15. Lothe RA, Hastie N, Heimdal K, Fossa SD, Stenwig AE, Borreson AL: Frequent loss of 11p13 and 11p15 loci in male germ cell tumours. Genes Chromosomes & Cancer 1993, 7:96-101
16. Shaw ME, Knowles MA: Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes & Cancer 1995, 13:1-8
17. Baffa R, Negrini M, Mandes B, Rugge M, Ranzani GN, Hirohashi S, Croce CM: Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res 1996, 56:268-272
18. Byrne JA, Simms LA, Little MH, Algar EM, Smith PJ: Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver. Genes Chromosomes & Cancer 1993, 8:104-111
19. Montagna M, Menin C, Chieco-Bianchi L, D'Andrea E: Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J Cancer Res Clin Oncol 1994, 120:732-736
20. Weksberg R, Squire JA: Molecular biology of Beckwith-Wiedemann syndrome. Med Pediatr Oncol 1996, 27:462-469
21. Weissmann BE, Saxon P, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ: Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 1987, 236:175-180
22. Dowdy SF, Fasching CL, Araujo D, Lai KM, Licanos E, Weissman BE, Stanbridge EJ: Suppression of tumorigenicity in Wilms tumor by the p15.5-15.4 region of chromosome 11. Science 1990, 254:293-295
23. Phillips KK, Welch DR, Miele ME, Lee J-H, Wei LL, Weissman BE: Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res 1996, 56:1222-1227
24. Negrini M, Sabbioni S, Possati L, Rattan S, Corallini, A, Barbanti-Brodano, G, Croce CM: Suppression of tumorigenicity of breast cancer cells by microcell mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 1994, 54:1331-1336
25. Modi WS, Lichy JH, Dean M, Seuanez HN, Howley PM: Human Gene Mapping 11 (1991). Cytogenet Cell Genet 1991, 58:1968
26. Redeker E, Alders M, Hoovers JMN, Richard CW III, Westerveld A, Mannens M: Physical mapping of 3 candidate tumor suppressor genes relative to Beckwith-Wiedemann syndrome associated chromosomal breakpoints at 11p15.3. Cytogenet Cell Genet 1995, 68: 222-225
27. Richard CW, Boehnke M, Berg DJ, Lichy JH, Meeker TC, Hauser E, Myers RM, Cox DR: A radiation hybrid map of the distal short arm of human chromosome 11, containing the Beckwith-Wiedemann and associated embryonal tumor disease loci. Am J Hum Genet 1993, 52:915-921
28. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996, 380:152-154
29. Redeker E, Hoovers JMN, Alders M, Van Moorsel CJA, Ivens AC, Gregory S, Kalikin L, Bliek J, de Galan L, van den Bogaard R, Visser J, van der Voort R, Feinberg AP, Little PFR, Westerveld A, Mannens M: An integrated physical map of 210 markers assigned to the short arm of human chromosome 11. Genomics 1994, 21:538-550
30. Litt M, Kramer P, Kort E, Fain P, Cox S, Root D, White R, Weissenbach J, Donis-Keller H, Gatti R, Weber J, Nakamura Y, Junien C, Hayashi K, Spurr N, Dean M, Mandel J, Kidd K, Kruse T, Retief A, et al: The CEPH consortium linkage map of human chromosome 11. Genomics 1995, 27:101-112
31. Cheng L, Song SY, Pretlow TG, Abdul-Karim FW, Kung HJ, Dawson DV, Park WS, Moon YW, Tsai ML, Linehan WM, Emmert-Buck MR, Liotta LA, Zhuang Z: Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 1998, 90:233-237
32. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998, 58:204-209
33. Macintosh CA, Stower M, Reid N, Maitland NJ: Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 1998, 58:23-28
34. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996, 274:2057-2059
35. Koi M, Johnson LA, Kalikin LM, Nakamura Y, Feinberg AP: Tumor cell growth arrest caused by subchromosomal transferrable DNA fragments from human chromosome 11. Science 1993, 260:361-364
36. Newsham I, Daub D, Besnard-Guerin C, Cavenee W: Molecular sub-localization and characterization of the 11;22 translocation breakpoint in a malignant rhabdoid tumor. Genomics 1994, 19:433-440
37. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen I-M, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD: Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nature Genet 1996, 12:154-158
38. Hoovers J, Kalikin LM, Johnson LA, Alders M, Redeker B, Law DJ, Bliek J, Steenman M, Benedict M, Wiegant J, Lengauer C, Taillonmiller P, Schlessinger D, Edwards MC, Elledge SJ, Ivens A, Westerveld A, Little P, Mannens M, Feinberg AP: Multiple genetic loci within 11p15 defined by Beckwith-Weidemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci USA 1995, 92:12456-12460
39. Lee MP, Hu R, Johnson LA, Feinberg AP: Human KVLQT1 gene shows tissue-specific imprinting, and encompasses Beckwith-Weidemann syndrome chromosomal rearrangements. Nature Genet 1997, 15:181-185
40. Lee M-H, Reynisdottir I, Massague J: Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995, 9:639-649
41. Li L, Cohen SN: Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 1996, 85:319-329
42. Lee MP, Feinberg AP: Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res 1997, 57:3131-3134